ID: ALA3594293

Max Phase: Preclinical

Molecular Formula: C15H20Cl2O4

Molecular Weight: 335.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCC(=O)c1c(O)c(Cl)c(O)c(Cl)c1O

Standard InChI:  InChI=1S/C15H20Cl2O4/c1-2-3-4-5-6-7-8-9(18)10-13(19)11(16)15(21)12(17)14(10)20/h19-21H,2-8H2,1H3

Standard InChI Key:  JNFMULWPXXTGMO-UHFFFAOYSA-N

Associated Targets(non-human)

Drosophila (190 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 335.23Molecular Weight (Monoisotopic): 334.0739AlogP: 5.04#Rotatable Bonds: 8
Polar Surface Area: 77.76Molecular Species: ACIDHBA: 4HBD: 3
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 5.24CX Basic pKa: CX LogP: 6.50CX LogD: 4.55
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.46Np Likeness Score: 0.73

References

1. Nguyen VH, Kikuchi H, Kubohara Y, Takahashi K, Katou Y, Oshima Y..  (2015)  Development of novel DIF-1 derivatives that selectively suppress innate immune responses.,  23  (15): [PMID:26122773] [10.1016/j.bmc.2015.06.027]

Source